• Capricor Therapeutics (CAPR) Raised to Buy at Zacks Investment Research

    Zacks Investment Research upgraded shares of Capricor Therapeutics (NASDAQ:CAPR) from a hold rating to a buy rating in a research note issued to …

    Read More
  • 0 0